Avian influenza (WHO)
World Health Organization (WHO) situation updates for Avian influenza. WHO is the directing and coordinating authority for health within the United Nations system. It is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries and monitoring and assessing health trends.
-
A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older
Oct 4, 2022 | 18:00 pmCondition: Seasonal InfluenzaInterventions: Biological: mRNA-1010; Biological: Licensed quadrivalent inactivated seasonal influenza vaccineSponsor: ModernaTX, Inc.Recruiting
-
Nationwide Utilization of Danish Government Electronic Letter System for Increasing InFLUenza Vaccine Uptake
Sep 15, 2022 | 18:00 pmConditions: Influenza; Behavior and Behavior MechanismsIntervention: Behavioral: Behavioral Economic PrinciplesSponsors: Tor Biering-Sørensen; Statens Serum Institut; Sanofi Pasteur, a Sanofi CompanyActive, not recruiting
-
Influenza Vaccine Uptake Among Healthcare Workers
Aug 30, 2022 | 18:00 pmCondition: Influenza VaccinesIntervention: Behavioral: ensuring the availability of influenza vaccine supply & developing influenza vaccine awarenessSponsors: International Centre for Diarrhoeal Disease Research, Bangladesh; Institute of Epidemiology, Disease Control and Research; Sylhet M.A.G.Osmani Medical College; Mymensingh Medical College Hospital; Rajshahi Medical College; Khulna Medical College Hospital; Centers for Disease Control and PreventionRecruiting
-
Phase Ⅲ, Clinical Trial to Compare an Inactivated Quadrivalent Influenza Vaccine and a Licensed Vaccine in Chile
Aug 9, 2022 | 18:00 pmConditions: Influenza; VaccinesIntervention: Drug: Tetravalent influenza vaccine developed by Sinovac Biotech Co.Sponsors: Pontificia Universidad Catolica de Chile; Sinovac Biotech (Chile) SpA; Sinovac Biotech Co., LtdRecruiting
-
Influenza Human Challenge Model
Apr 18, 2022 | 18:00 pmCondition: InfluenzaIntervention: Biological: Influenza Virus Type A H3N2 ChallengeSponsor: Emory UniversityRecruiting
-
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
Jan 31, 2022 | 18:00 pmConditions: Immunization; Infection; Transplantation Infection; InfluenzaInterventions: Biological: High Dose Quadrivalent Inactivated Influenza Vaccine; Biological: Standard Dose Quadrivalent Inactivated Influenza VaccineSponsors: Vanderbilt University Medical Center; Northwestern University Feinberg School of Medicine; University of Alabama at Birmingham; University of Washington; Duke UniversityRecruiting
-
A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years
Dec 3, 2021 | 18:00 pmCondition: InfluenzaIntervention: Biological: Quadrivalent influenza vaccineSponsors: Jiangsu Province Centers for Disease Control and Prevention; Jiangsu Jindike Biotechnology Co., Ltd.Enrolling by invitation
-
Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults
Nov 5, 2021 | 17:00 pmCondition: Influenza, HumanIntervention: Biological: Seasonal influenza vaccineSponsors: University of Pennsylvania; National Institute of Allergy and Infectious Diseases (NIAID); Stanford University; The Scripps Research InstituteRecruiting
-
Efficacy of Different Doses of Influenza Vaccine in Chronic Hemodialysis Patients
Oct 7, 2021 | 18:00 pmConditions: ESRD; Influenza Vaccine; SeroprotectionIntervention: Biological: Egg-derived standard dose trivalent influenza vaccine (surface antigen, inactivated)Sponsors: Mahidol University; Bhumirajanagarindra Kidney Institute, Thailand; Ministry of Health, ThailandRecruiting
-
High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients
Nov 3, 2020 | 18:00 pmConditions: Immunization; Infection; Transplantation Infection; Influenza; Solid Organ TransplantInterventions: Biological: High Dose Quadrivalent Inactivated Influenza Vaccine; Biological: Standard Dose Quadrivalent Inactivated Influenza VaccineSponsors: Vanderbilt University Medical Center; Northwestern University Feinberg School of Medicine; University of Alabama at Birmingham; University of WashingtonRecruiting
-
Broadening Our Understanding of Early Versus Late Influenza Vaccine Effectiveness
Sep 30, 2020 | 18:00 pmConditions: Influenza; Influenza -Like IllnessIntervention: Biological: Influenza vaccination at different time pointsSponsors: University of Leicester; Sanofi Pasteur, a Sanofi Company; World Health Organization; University of Warwick; University Hospitals, LeicesterCompleted
-
Nasal and Systemic Immune Responses to Nasal Influenza Vaccine
Oct 1, 2019 | 18:00 pmConditions: Influenza; Vaccine Virus SheddingInterventions: Biological: Live attenuated influenza vaccine; Other: Vehicle controlSponsor: Imperial College Healthcare NHS TrustCompleted
-
Response to Inactivated Influenza Vaccine in Lymph Tissue and Blood
Apr 2, 2019 | 18:00 pmCondition: InfluenzaIntervention: Biological: Quadrivalent inactivated influenza vaccine (IIV)Sponsors: Stanford University; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)Recruiting
-
Response to Influenza Vaccine During Pregnancy
Mar 25, 2019 | 17:00 pmCondition: InfluenzaIntervention: Biological: Quadrivalent inactivated influenza vaccine (IIV)Sponsors: Stanford University; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)Recruiting
-
Response to Live Attenuated Influenza Vaccine in Tonsillar Tissues and Blood
Mar 21, 2019 | 17:00 pmCondition: InfluenzaIntervention: Biological: FluMistSponsors: Stanford University; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)Recruiting
-
Influenza Vaccine Responses
Jul 27, 2018 | 18:00 pmCondition: InfluenzaInterventions: Drug: Fluad Vaccine; Drug: Fluzone High-DoseSponsors: Mayo Clinic; National Institute of Allergy and Infectious Diseases (NIAID)Active, not recruiting
-
Improved Novel VaccIne CombinaTion InflUenza Study
Oct 3, 2017 | 18:00 pmCondition: InfluenzaInterventions: Drug: Seasonal influenza vaccine; Drug: MVA-NP+M1; Drug: Sodium chlorideSponsors: Vaccitech (UK) Limited; University of OxfordTerminated
-
Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute
Feb 20, 2017 | 18:00 pmCondition: Influenza VaccinesIntervention: Biological: Seasonal Influenza vaccineSponsor: Butantan InstituteCompleted
-
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Sep 27, 2016 | 18:00 pmCondition: InfluenzaIntervention: Biological: Fluzone Quadrivalent vaccine, No PreservativeSponsor: Sanofi Pasteur, a Sanofi CompanyCompleted
-
Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine
Jun 30, 2016 | 18:00 pmCondition: InfluenzaIntervention: Biological: Butantan Fragmented Inactivated Trivalent Influenza VaccineSponsor: Butantan InstituteCompleted
